Akebia Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-07 11:40:57 ET AKBA

Published on 05/07/2026 at 11:40 am EDT

Akebia Therapeutics, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 53.54 million compared to USD 57.34 million a year ago. Net loss was USD 9.05 million compared to net income of USD 6.11 million a year ago.

Basic loss per share from continuing operations was USD 0.03 compared to basic earnings per share from continuing operations of USD 0.03 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to diluted earnings per share from continuing operations of USD 0.03 a year ago.